Page last updated: 2024-08-23

amikacin and hr 810

amikacin has been researched along with hr 810 in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's6 (60.00)18.2507
2000's2 (20.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Carattoli, A; Ellington, MJ; Karisik, E; Livermore, DM; Underwood, A; Woodford, N1
Girlich, D; Nordmann, P; Poirel, L1
Klesel, N; Limbert, M; Seibert, G1
Elkhaïli, H; Jehl, F; Kamili, N; Linger, L; Monteil, H; Pompei, D1
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y1
Jacolot, A; Louchahi, K; Mimoz, O; Padoin, C; Petitjean, O; Quillard, J; Samii, K; Tod, M1
Elkhaïli, H; Jehl, F; Levêque, D; Linger, L; Monteil, H; Niedergang, S; Peter, JD; Pompei, D; Salmon, J; Salmon, Y; Thierry, RC1
Canis, F; Cavallo, JD; Husson, MO1
Bessho, M; Endo, K; Fukuda, M; Hirashima, K; Kawai, N; Kobayashi, Y; Tominaga, K1

Trials

1 trial(s) available for amikacin and hr 810

ArticleYear
[Clinical evaluation of combination therapy with cefpirome and amikacin for infections associated with hematological disorders].
    The Japanese journal of antibiotics, 1998, Volume: 51, Issue:4

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefpirome; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Treatment Outcome

1998

Other Studies

9 other study(ies) available for amikacin and hr 810

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10

    Topics: beta-Lactamases; Computational Biology; Escherichia coli; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Plasmids; United Kingdom

2009
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology

2010
Synergistic activity in vitro of the new cephalosporin antibiotic HR 810 with gentamicin and amikacin against multiresistant pathogens.
    The Journal of antibiotics, 1984, Volume: 37, Issue:8

    Topics: Amikacin; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Kanamycin

1984
[Kinetics of bactericidal activity of cefepime and cefpirome alone or combined with gentamicin, amikacin or ciprofloxacin against Acinetobacter baumannii, Stenotrophomonas maltophilia and Enterobacter cloacae hyperproductive in cephalosporinase].
    Pathologie-biologie, 1996, Volume: 44, Issue:5

    Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cefpirome; Cephalosporinase; Cephalosporins; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enterobacter cloacae; Gentamicins; In Vitro Techniques; Xanthomonas

1996
[Antibacterial activities of combination uses of cefpirome with various antibiotics in vitro against clinically isolated glucose non-fermentative gram-negative rods: part 1. the results against Pseudomonas aeruginosa].
    The Japanese journal of antibiotics, 1996, Volume: 49, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefpirome; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Imipenem; Piperacillin; Pseudomonas aeruginosa; Tobramycin

1996
Influence of experimental rat model of multiple organ dysfunction on cefepime and amikacin pharmacokinetics.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:3

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Half-Life; Lung; Multiple Organ Failure; Rats

1996
[In vivo pharmacokinetic of amikacin and its pharmacodynamic in combination with cefepime, cefpirome and meropenem in an in vitro/ex vivo micropig model].
    Pathologie-biologie, 1997, Volume: 45, Issue:5

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Cefpirome; Cephalosporins; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Klebsiella pneumoniae; Meropenem; Perfusion; Serum Bactericidal Test; Swine; Thienamycins

1997
[Evaluation of bactericidal activity of cefpirome-aminoglycoside combination against Pseudomonas aeruginosa strains with intermediate sensitivity to cefpirome and in various phenotypes of beta-lactam resistance].
    Pathologie-biologie, 1997, Volume: 45, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; In Vitro Techniques; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Tobramycin

1997